NCT05690204 Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05665699 Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05658575 Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Status RECRUITING Phase PHASE2/PHASE3
NCT05586971 Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Status COMPLETED Phase PHASE3
NCT05586958 Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Status COMPLETED Phase PHASE3
NCT05546593 Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout Status RECRUITING Phase N/A
NCT05499312 An Innovative Chinese Herbal Formula for the Treatment of Gout Status UNKNOWN Phase PHASE2
NCT05473325 Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) Status UNKNOWN Phase N/A
NCT05454423 Effect of Aquatic Exercise and Traditional Physical Therapy on Gout in Hypertensive Menopausal Women With Hyperuricemia Status UNKNOWN Phase NA
NCT05324423 To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout Status UNKNOWN Phase PHASE1
NCT05309057 Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk Status UNKNOWN Phase N/A
NCT05289544 Phone-Based Based Walk With Ease Program for Adults With Arthritis Status COMPLETED Phase NA
NCT05256810 A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout Status TERMINATED Phase PHASE1/PHASE2
NCT05253833 Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout Status COMPLETED Phase PHASE2
NCT05168683 Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets Status COMPLETED Phase PHASE1
NCT05127772 A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing Status COMPLETED Phase PHASE1
NCT05119686 Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients Status COMPLETED Phase PHASE2